TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

LSL/MED/0135 - Supply of Pfizer Branded Pharmaceuticals

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Ministry of Defence, DE&S, LDOC, CMO Commercial: "LSL/MED/0135 - Supply of Pfizer Branded Pharmaceuticals". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMinistry of Defence, DE&S, LDOC, CMO CommercialScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Ministry of Defence, DE&S, LDOC, CMO Commercial
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Ministry of Defence, DE&S, LDOC, CMO Commercial. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMinistry of Defence, DE&S, LDOC, CMO Commercial
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published14 Sept 2022, 14:06 BST
Last source update14 Sept 2022, 14:06 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-03686a
What is being bought
Leidos Supply Ltd. intends to award a single source framework for the provision of Pfizer Branded Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation 32(2)(b) of Public Contracts Regulations 2015. These products are manufactured by Pfizer and are only available through a contract direct with Pfizer.
What changed
From the official release history
  1. Status changed to complete
    14 Sept 2022, 14:06 BST
  2. Official notice release published
    14 Sept 2022, 14:06 BST
  3. Buyer information updated
    14 Sept 2022, 14:06 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Team Leidos are proud to be delivering the logistics commodities and services transformation (LCS(T)) Delivery partner Contracts (LCS (T)/0001 dated 16.4.2015) on behalf of the UK Ministry of Defence (the ‘Prime Contract’). Delivery of other parts of the LCS(T) contract are delivered by Leidos Europe Ltd (LEL) and other partners (together ‘Team Leidos’). Please note all information provided to organisations or individuals that respond to this notice should be treated as Confidential, and not shared further without express written permission from Leidos Supply Ltd. Negotiated procedure without prior publication The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights Explanation: Leidos Supply Ltd intends to award a single source framework for the provision of Pfizer Branded Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32(2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation32(2)(b) of Public Contracts Regulations 2015. This is because the manufacturer has the exclusive rights, including intellectual property rights in respect to these products. The products covered by this framework are manufactured solely by Pfizer Ltd, available to contract direct with Pfizer Ltd. and distributed through Alliance Healthcare, who are Pfizer Ltd’s only authorised distributor.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    14 Sept 2022, 14:06 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 13 Sept 2022, 00:00 BST · Not published
Commercial outcome and competition
Awards
Pfizer Ltd.
Not published · Not published · active
Contracts
LSL/MED/0135 - Supply of Pfizer Branded Pharmaceuticals
Not published · signed 13 Sept 2022, 00:00 BST · active
Bid statistics
highestValidBidValue: 5000000
lowestValidBidValue: 4500000
highestValidBidValue: 5000000 (lot 1)
lowestValidBidValue: 4500000 (lot 1)
Buyer and organisations in this procedure

Ministry of Defence, DE&S, LDOC, CMO Commercial

Contracting authority GB-FTS-63506
View buyer profile

  • Ministry of Defence, DE&S, LDOC, CMO Commercial
    buyer

    MOD Abbey Wood, Cedar 2a, Mailpoint #3237, Bristol, UK, BS34 8JH
    lana.douglass101@teamleidos.mod.uk

  • Leidos Supply Ltd.
    reviewBody

    Bristol

  • Pfizer Ltd.
    supplier

    Walton Oaks, Dorking Road, Walton-on-the-Hill, UK, KT20 7NS
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleNegotiated procedure without prior publication The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights Explanation: Leidos Supply Ltd intends to award a single source framework for the provision of Pfizer Branded Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32(2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation32(2)(b) of Public Contracts Regulations 2015. This is because the manufacturer has the exclusive rights, including intellectual property rights in respect to these products. The products covered by this framework are manufactured solely by Pfizer Ltd, available to contract direct with Pfizer Ltd. and distributed through Alliance Healthcare, who are Pfizer Ltd’s only authorised distributor.